Mechanisms of Erythropoietin-Mediated Protection Against Retinal Ganglion Cell Apoptosis.

红细胞生成素介导的视网膜神经节细胞凋亡保护机制

阅读:30
作者:Chen Wangling, Lao Wei, Chen Yunxin, Liang Xiaoqian
BACKGROUND Retinal ganglion cells (RGCs), as cells located in the innermost layer of the retina, are the last cells in the eye neural network to receive visual stimuli. This study aimed to investigate the effects of erythropoietin (EPO) on apoptosis of RGCs and clarify the mechanisms. MATERIAL AND METHODS RGCs were isolated from the mice retinas, purified with the immunopanning method, and identified by immunohistochemical assay. EPO-overexpressed lentivirus (Ov-EPO) was constructed and infected to RGCs. CCK-8 assay and TUNEL assay were used to determine RGC viability and apoptosis, respectively. RT-qPCR assay was applied to detect transcriptions of the Bcl-2, AKT1, STAT5A, and MAPK genes in RGCs treated with Ov-EPO and/or H₂O₂/NMDA. RESULTS Ov-EPO lentivirus was successfully established, showing higher expressing efficacy. TUNEL findings showed that EPO overexpression inhibited apoptosis of RGCs. EPO overexpression resisted oxidative damage, and excitatory toxicity caused cell death. EPO overexpression significantly increased the transcription of the AKT1 and STAT5A gene, compared with those of the blank group, suggesting activated PI3K/Akt and JAK/STAT signaling pathway in RGCs. The transcription of the MAPK gene in EPO-overexpressed RGCs was significantly increased compared with that of the RGCs of the blank group (P<0.01), suggesting that EPO overexpression is associated with the MAPK/ERK signaling pathway. CONCLUSIONS EPO played a protective role for RGC viability, and Bcl-2 played a critical role in this process. EPO inhibited apoptosis, oxidative damage, and excitatory toxicity of RGCs, which involved the potential PI3K/Akt-JAK/STAT-MAPK/ERK signaling pathway.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。